Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Average Recommendation of "Buy" by Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been given an average rating of "Buy" by the six analysts that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $10.00.

A number of brokerages have issued reports on BIOX. Canaccord Genuity Group decreased their target price on shares of Bioceres Crop Solutions from $9.50 to $7.00 and set a "buy" rating for the company in a research note on Friday. Lake Street Capital decreased their target price on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a research note on Friday. Finally, Oppenheimer decreased their target price on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating for the company in a research note on Tuesday, January 28th.

Bioceres Crop Solutions Trading Down 2.5 %

Bioceres Crop Solutions stock traded down $0.14 during midday trading on Friday, reaching $5.55. The stock had a trading volume of 324,519 shares, compared to its average volume of 247,720. The firm's fifty day simple moving average is $6.59 and its two-hundred day simple moving average is $7.74. Bioceres Crop Solutions has a twelve month low of $5.50 and a twelve month high of $14.05. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. The firm has a market cap of $348.04 million, a price-to-earnings ratio of 277.64 and a beta of 0.57.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). The firm had revenue of $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same period in the prior year, the business posted ($0.07) EPS. Equities analysts anticipate that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Stifel Financial Corp raised its holdings in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock worth $321,000 after acquiring an additional 10,224 shares during the period. Ping Capital Management Inc. raised its holdings in Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock worth $268,000 after acquiring an additional 3,000 shares during the period. Dimensional Fund Advisors LP raised its holdings in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after acquiring an additional 5,341 shares during the period. JPMorgan Chase & Co. raised its holdings in Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after acquiring an additional 29,693 shares during the period. Finally, Fourth Sail Capital LP raised its holdings in Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock worth $24,957,000 after acquiring an additional 1,209,277 shares during the period. Institutional investors own 17.68% of the company's stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.